ARQ 197 News
Most Popular ARQ 197 Story
ArQule shares skyrocket on promising Phase II lung cancer data
Shares of Woburn, MA-based ArQule soared 57 percent in pre-market trading this morning as investors responded to the news that its lead drug in combination with Tarceva improved the median Read more...
Latest Headlines
- November 10, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
